Table 4.
Genes related to GAG metabolism and extracellular matrix dynamics differentially expressed between Mobilee™ and placebo groups post-intervention (p < 0.05), but not pre-intervention
Gene | Name | Systematic name | Function | Fold change Mobilee™ vs. placebo | p value |
---|---|---|---|---|---|
GUSB | Glucuronidase-beta | NM_000181 | Hydrolase that degradates GAG | −1.22 | 0.027 |
HS6ST1 | Heparan sulfate 6-O-sulfotransferase 1 | NM_004807 | Enzyme responsible for 6-O-sulfation of heparan sulfate | −1.22 | 0.009 |
MMP23B | Matrix metallopeptidase 23B | NM_006983 | Protease involved in the breakdown of the extracellular matrix | −1.30 | 0.028 |
XYLT2 | Xylosyltransferase II | NM_022167 | Enzyme that initiates the biosynthesis of GAGs including chondroitin sulfate, heparan sulfate, heparin, and dermantan sulfate in proteoglycans | −1.32 | 0.004 |